Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.05.2016 | Case report

Gimeracil/oteracil/tegafur

Idiopathic thrombocytopenic purpura: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Takahara Y, et al. [A Case of Idiopathic Thrombocytopenic Purpura during Adjuvant Chemotherapy for Colon Cancer]. [Japanese]. Gan to Kagaku Ryoho 42: 2145-7, No. 12, Nov 2015 [Japanese; summarised from a translation] - JapanPubMed Takahara Y, et al. [A Case of Idiopathic Thrombocytopenic Purpura during Adjuvant Chemotherapy for Colon Cancer]. [Japanese]. Gan to Kagaku Ryoho 42: 2145-7, No. 12, Nov 2015 [Japanese; summarised from a translation] - JapanPubMed
Metadaten
Titel
Gimeracil/oteracil/tegafur
Idiopathic thrombocytopenic purpura: case report
Publikationsdatum
01.05.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-17433-6

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Vemurafenib

Case report

Cetuximab

Case report

Codeine

Case report

Vaccines